Deliver to United Kingdom
0

HPLC column NUCLEODUR ® π 2 , 5 µm, 250 mm, 4 mm

£ 720.81*

*Prices plus VAT plus shipping costs

£ 864.97*

*incl. VAT, plus shipping costs

HPLC column NUCLEODUR ® π 2 , 5 µm, 250 mm, 4 mm

Order number: 34XY.1

Part number: AC100007609

In Stock

Price Breakdown

1

6

24

A reliable solution for controlled synthesis, the Hplc Column Nucleodur ® Π 2, 5 μm, 250 mm, 4 mm offers exceptional performance under highly aqueous conditions. Its unique biphenylpropyl modification ensures superior retention of aromatic and unsaturated substances, making it particularly suitable for antibiotics, pharmaceutical products, steroids, and other polar compounds. With a pore size of 110 Å, this fully porous particle (FPP) column boasts a specific surface area of 340 m²/g, providing ample space for efficient separations. The reversed phase (RP) column, featuring a pressure stability of 600 bar and temperature stability up to 60 °C, is ideal for use with acetonitrile-water eluents. This analytical separation column, available in

  • Category: Separation columns for HPLC
  • USP listing: L11
  • Pressure stability: 600 bar
  • Column shape: Analytical separation column
  • Endcapped: yes
  • Column volume: 3.15 ml
  • Pore volume: 0.9 ml/g
  • Phase: π 2
  • Surface chemistry: Biphenylpropyl modification
  • Separation principle: Reversed phase (RP)
  • Interactions / retention mechanism: π-π and hydrophobic
  • Particle size: 5 µm
  • Column type: HPLC column
  • Temperature stability: 60 ° C
  • Recommended application(s): Antibiotics Particularly aromatic and unsaturated compounds Pharmaceutical products Especially for polar compounds Steroids
  • Particle type: Fully porous particles (FPP)
  • pH stability: 3,0-10,0
  • L x Ø internal (column): 250 x 4 mm
  • Eluent in column: Acetonitrile - Water
  • Specific surface according to BET: 340 m²/g
  • Application Database (Macherey-Nagel): HPLC
  • Pore size: 110 Å
allied chemi
  • secure-payment
  • visa
  • american-express
  • master-card

© 2026 Copyright. All Rights Reserved.